• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy

    Angi Inc. filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders, Financial Statements and Exhibits

    6/18/25 4:38:45 PM ET
    $ANGI
    Advertising
    Consumer Discretionary
    Get the next $ANGI alert in real time by email
    angi-20250617
    0001705110FALSE00017051102025-06-172025-06-17

     
    UNITED STATES
    SECURITIES AND EXCHANGE COMMISSION
    WASHINGTON, D.C. 20549
     
    FORM 8-K
     
    CURRENT REPORT
    Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
     
    Date of Report (Date of earliest event reported): June 17, 2025
     
    Angi Inc.
    (Exact name of registrant as specified in charter)
     
    Delaware 001-38220 82-1204801
    (State or other jurisdiction
    of incorporation)
     (Commission
    File Number)
     (IRS Employer
    Identification No.)
     
    3601 Walnut Street,
     Suite 700
    Denver,
    CO
     80205
    (Address of principal executive offices) (Zip Code)
     
    Registrant’s telephone number, including area code: (303) 963-7200 
    (Former name or former address, if changed since last report)
     
    Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
    ☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
    ☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
    ☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
    ☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

    Securities registered pursuant to Section 12(b) of the Act:
    Title of each classTrading Symbol(s)Name of each exchange on which registered
    Class A Common Stock, par value $0.001ANGI
    The Nasdaq Stock Market LLC
    (Nasdaq Global Select Market)
     
    Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter). Emerging growth company ☐
     
    If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐



      
    Item 5.07    Submission of Matters to a Vote of Security Holders.

    On June 17, 2025, Angi Inc. (“Angi” or the “Company”) held its Annual Meeting of Stockholders (the “Annual Meeting”). At the Annual Meeting, stockholders of the Company voted on the proposals set forth below. These proposals are described in detail in the Company’s definitive proxy statement related to the Annual Meeting filed on April 30, 2025 with the U.S. Securities and Exchange Commission (the “SEC”). The final voting results on each of the matters submitted to a vote of the Company’s stockholders at the Annual Meeting are set forth below.

    As of the close of business on April 21, 2025, the record date for the Annual Meeting, there were 47,950,314 shares of Angi Class A common stock outstanding and entitled to vote.

    1.        A proposal to elect four Class I members of the Angi board of directors, each to hold office until the 2028 annual meeting of stockholders or until such director’s successor shall have been duly elected and qualified (or, if earlier, such director’s removal or resignation from the Angi board of directors). The stockholders elected each of the nominees to the Angi board of directors on the basis of the following voting results:

    FOR
    WITHHOLD
    BROKER NON-VOTE
    Thomas R. Evans
    28,878,2045,327,2035,373,888
    Alesia J. Haas
    33,091,5461,113,8615,373,888
    Jeffrey W. Kip
    33,426,498778,9095,373,888
    Joseph Levin
    31,709,8682,495,5395,373,888


    2.        A proposal to ratify the appointment of Ernst & Young LLP as Angi’s independent registered public accounting firm for the 2025 fiscal year. This proposal was approved by the holders of Angi Class A common stock on the basis of the following voting results:

    FOR
    AGAINST
    ABSTAIN
    39,487,27374,05917,963

    Item 9.01. Financial Statements and Exhibits

    Exhibit
    Number
    Description
    104Cover Page Interactive Data File (embedded within the Inline XBRL)





    SIGNATURES

    Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
    ANGI INC.
    By:/s/ Shannon M. Shaw
    Name:Shannon M. Shaw
    Title:Chief Legal Officer
    Date: June 18, 2025

    Get the next $ANGI alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $ANGI

    DatePrice TargetRatingAnalyst
    6/16/2025Mkt Outperform → Mkt Perform
    Citizens JMP
    12/18/2024Overweight → Neutral
    Analyst
    11/13/2024$3.25 → $2.50Buy → Neutral
    Goldman
    11/13/2024$3.25 → $2.00Buy → Neutral
    Citigroup
    7/9/2024$3.25Mkt Outperform
    JMP Securities
    2/15/2023$2.00 → $2.75Sell → Neutral
    UBS
    12/13/2022$2.60Buy
    Citigroup
    12/2/2022$2.00Sell
    UBS
    More analyst ratings